{
  "report_rows": [
    {
      "kpi": "EBIT-Adjusted (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$4.1B vs. cons $3.589B (Visible Alpha, Jul 17, 2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Adj. EPS Diluted (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$3.75 vs. cons $3.20 (Visible Alpha, Jul 17, 2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "NA EBIT-Adjusted (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$3.7B vs. cons $3.231B (Visible Alpha, Jul 17, 2026)",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "EBIT-Adjusted FY 2026 (midpoint)",
      "prediction": "BETTER",
      "answer": "guide ~$14.75B vs. cons $14.714B (Visible Alpha, Jul 17, 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. EPS FY 2026 (midpoint)",
      "prediction": "LOWER",
      "answer": "guide ~$12.75 vs. cons $12.863 (Visible Alpha, Jul 17, 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adj. Auto FCF FY 2026",
      "prediction": "BETTER",
      "answer": "guide maintained $9-11B vs. cons $8.494B (Visible Alpha, Jul 17, 2026)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 3.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.0,
  "day5_path": "FADE",
  "day5_rationale": "FADE - beat absorbed day-1; EPS guide midpoint below consensus pulls estimates flat-to-down; stock stabilizes above pre-print levels",
  "day5_confidence": "MEDIUM"
}